Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Tuesday it plans to exercise its option to acquire the full US rights to the Tudorza chronic obstructive pulmonary disease drug from to
11 Dec 18 13:15NEW DELHI (Alliance News) - Dr. Reddy's Laboratories Ltd announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter store-brand equivalent of Prilosec OTC Tablets,
11 Dec 18 06:50LONDON (Alliance News) - Pharmaceticals form AstraZeneca PLC on Friday said its phase three Eagle trial of Imfinzi in advanced head and neck cancer patients failed to meet its primary study alone,
7 Dec 18 08:36(Sharecast News) - AstraZeneca and its global biologics research and development arm MedImmune announced overall survival results for the Phase III EAGLE trial of Imfinzi (durvalumab) on Friday.
7 Dec 18 07:24BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Thursday's session sharply lower, extending the losses from the previous two days. Falling crude oil prices and the
6 Dec 18 17:32(Sharecast News) - AstraZeneca has completed an agreement with Covis Pharma to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with rhinitis.
6 Dec 18 07:23LONDON (Alliance News) - Majedie Investments PLC on Wednesday reported a decrease in net asset value over its financial year due to making higher dividend payouts and redeeming debentures, as its
5 Dec 18 11:56LONDON (Alliance News) - AstraZeneca PLC on Monday presented long-term follow-up data from a trial of Calquence in chronic lymphocytic leukaemia patients which showed a sustained a meaningful to a
4 Dec 18 18:27LONDON (Alliance News) - AstraZeneca PLC said Monday it has completed an agreement to divest the prescription medicine rights to Nexium in Europe and the global rights, excluding the US and Japan,
3 Dec 18 08:12(Sharecast News) - AstraZeneca has completed an agreement to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights - excluding the US and Japan - to Vimovo (naproxen/esomeprazole), to Grunenthal, it announced on Monday.
3 Dec 18 07:25LONDON (Alliance News) - Belgium-based diagnostics firm Biocartis Group NV on Thursday unveiled an agreement with AstraZeneca PLC in which the two will work to improve the speed of lung cancer be
29 Nov 18 10:12LONDON (Alliance News) - AstraZeneca PLC said Monday the US Food & Drug Administration has granted orphan drug designation to Fasenra for the treatment of eosinophilic granulomatosis with a to
26 Nov 18 08:21(Sharecast News) - AstraZeneca on Monday said its Fasenra treatment for the autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA) had been granted Orphan Drug Designation (ODD) by the US Food and Drug Administration (FDA).
26 Nov 18 07:18LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new
19 Nov 18 13:07(Sharecast News) - Sainsbury: Berenberg reiterates buy with a target price of 369p.
19 Nov 18 12:13
Last checked at